Tiger Brokers

HK StockDetailed Quotes
Provided by Tiger Fintech (Singapore) Pte. Ltd.

OCUMENSION-B

10.440
-0.080-0.76%
Volume:2.54M
Turnover:26.49M
Market Cap:8.50B
PE:-24.31
High:10.720
Open:10.520
Low:10.240
Close:10.520
Loading ...
OverviewCompanyNewsFilings

Company Profile

Company Name:
OCUMENSION-B
Exchange:
SEHK
Establishment Date:
2017
Employees:
489
Office Location:
No. 1858 Yinzhongnan Road,Guoxiang Subdistrict,Wuzhong District,Suzhou,Jiangsu Province,China
Website:
http://www.ocumension.com
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Ocumension Therapeutics is a China-based holding company principally involved in the discovering, developing and commercializing ophthalmic therapies. Its main products include OT-401 (YUTIQ), OT-1001 (ZERVIATE), OT-502 (DEXYCU), OT-301 (NCX 470), OT-101 and OT-202, among others. The Company conducts its businesses in the domestic market.

Directors

Name
Position
CHEN Lian Yong
Chairman of the Board,Director,Chairman of the Nomination Committee
LIU Ye
Executive Director
HU Zhao Peng
Executive Director
WU Ting Yuk Anthony
Independent Director,Member of the Remuneration and Assessment Committee,Audit Committee Chairman
HUANG Yi Ran
Independent Director,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Member
ZHANG Zhen Yu
Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee,Audit Committee Member
CAO Yan Ling
Director
XIE Qin
Director

Shareholders

Name
Position
LIU Ye
CEO
HU Zhao Peng
Vice General Manager,Other Senior Executives
RUAN Tian Shi
CFO,Corporate Secretary
CHEN Ting Chan
Board Secretary,Corporate Secretary
ZUO Qing Lei
Chief Commercial Officer
CHEN Dong Hong
Other Senior Executives
LIU Hong Ying
Other Senior Executives,Other Senior Executives
CHEN Yang
Other Senior Executives